Tuesday, January 21
3M (MMM)
- Date/Time: Jan 21, 6:30 AM (ET)
- Est. Revenue: $5.85B
- Est. EPS: $1.55
- Key Focus: Investors await updates on 3M’s restructuring efforts and how broader economic headwinds are impacting its industrial segment.
Charles Schwab (SCHW)
- Date/Time: Jan 21, 7:30 AM (ET)
- Est. Revenue: $5.13B
- Est. EPS: $0.89
- Key Focus: Market volatility and client asset flows will be top of mind, especially regarding trading volumes and net interest income.
D.R. Horton (DHI)
- Date/Time: Jan 21, 6:30 AM (ET)
- Est. Revenue: $7.12B
- Est. EPS: $2.39
- Key Focus: Housing demand remains robust, so updates on supply chain constraints and new home order trends will be critical.
Prologis (PLD)
- Date/Time: Jan 21, 8:00 AM (ET)
- Est. Revenue: $1.94B
- Est. EPS: $1.38
- Key Focus: E-commerce continues to drive demand for industrial real estate, prompting interest in occupancy rates and rent escalations.
Netflix (NFLX)
- Date/Time: Jan 21, 4:00 PM (ET)
- Est. Revenue: $10.13B
- Est. EPS: $4.20
- Key Focus: Subscriber growth and content spending remain pivotal amid intensifying streaming competition.
Interactive Brokers (IBKR)
- Date/Time: Jan 21, 4:00 PM (ET)
- Est. Revenue: $1.37B
- Est. EPS: $1.82
- Key Focus: Rising interest rates may bolster brokerage revenues; analysts will look for commentary on client account growth and margin lending.
Capital One (COF)
- Date/Time: Jan 21, 4:05 PM (ET)
- Est. Revenue: $10.21B
- Est. EPS: $2.71
- Key Focus: Credit quality, consumer spending trends, and net interest margins will be in the spotlight.
United Airlines (UAL)
- Date/Time: Jan 21, 4:00 PM (ET)
- Est. Revenue: $14.26B
- Est. EPS: $2.46
- Key Focus: Fuel costs and demand recovery are central to the airline’s outlook as travel rebounds.
Seagate Technology (STX)
- Date/Time: Jan 21, 4:05 PM (ET)
- Est. Revenue: $2.32B
- Est. EPS: $1.87
- Key Focus: Demand for storage solutions and any ongoing supply chain challenges will guide STX’s forward sentiment.
Wednesday, January 22
Johnson & Johnson (JNJ)
- Date/Time: Jan 22, 6:20 AM (ET)
- Est. Revenue: $22.45B
- Est. EPS: $2.04
- Key Focus: Pharma pipeline developments and any progress on consumer health spinoffs will attract investor attention.
Procter & Gamble (PG)
- Date/Time: Jan 22, 6:55 AM (ET)
- Est. Revenue: $21.67B | Est. EPS: $1.87
- Key Focus: Price increases driven by inflation and shifting consumer behavior will be scrutinized for their effect on margins.
GEV Corp. (GEV)
- Date/Time: Jan 22, 6:30 AM (ET)
- Est. Revenue: $10.69B | Est. EPS: $2.47
- Key Focus: Global expansion and supply chain efficiency could significantly influence GEV’s performance.
Abbott Laboratories (ABT)
- Date/Time: Jan 22, 7:30 AM (ET)
- Est. Revenue: $11.04B
- Est. EPS: $1.34
- Key Focus: Nutrition, diagnostics, and any new product rollouts in medical devices are top of mind for investors.
Ally Financial (ALLY)
- Date/Time: Jan 22, 7:30 AM (ET)
- Est. Revenue: $2.01B
- Est. EPS: $0.64
- Key Focus: Auto lending trends and credit quality will be monitored in light of changing interest rate environments.
Halliburton (HAL)
- Date/Time: Jan 22, 6:45 AM (ET)
- Est. Revenue: $5.63B
- Est. EPS: $0.70
- Key Focus: Oilfield services demand and international expansion efforts remain crucial to HAL’s results.
Discover Financial Services (DFS)
- Date/Time: Jan 22, 4:20 PM (ET)
- Est. Revenue: $4.39B
- Est. EPS: $3.26
- Key Focus: Credit card usage and delinquency rates are central to the company’s outlook, reflecting broader consumer spending.
Thursday, January 23
General Electric (GE)
- Date/Time: Jan 23, 6:30 AM (ET)
- Est. Revenue: $9.84B
- Est. EPS: $1.05
- Key Focus: Restructuring progress, especially in aviation and renewable energy, will shape GE’s future.
Union Pacific (UNP)
- Date/Time: Jan 23, 7:45 AM (ET)
- Est. Revenue: $6.26B
- Est. EPS: $2.92
- Key Focus: Supply chain disruptions and freight demand levels remain pivotal for UNP’s performance.
American Airlines (AAL)
- Date/Time: Jan 23, 7:00 AM (ET)
- Est. Revenue: $13.13B
- Est. EPS: $0.39
- Key Focus: Travel demand recovery, cost controls, and fuel prices will drive investor sentiment.
Freeport-McMoRan (FCX)
- Date/Time: Jan 23, 8:00 AM (ET)
- Est. Revenue: $6.27B
- Est. EPS: $0.35
- Key Focus: Copper pricing and global economic indicators remain the biggest drivers of FCX’s earnings.
Elevance Health (ELV)
- Date/Time: Jan 23, 6:00 AM (ET)
- Est. Revenue: $44.63B
- Est. EPS: $3.87
- Key Focus: Enrollment trends and medical cost management will be closely watched given ongoing policy changes.
Texas Instruments (TXN)
- Date/Time: Jan 23, 4:01 PM (ET)
- Est. Revenue: $4.12B
- Est. EPS: $1.37
- Key Focus: Semiconductor demand in automotive and industrial sectors is crucial for TXN’s guidance.
Intuitive Surgical (ISRG)
- Date/Time: Jan 23, 4:05 PM (ET)
- Est. Revenue: $2.2B
- Est. EPS: $1.75
- Key Focus: The adoption rate of robotic-assisted surgery and new system placements drive ISRG’s growth prospects.
Friday, January 24
American Express (AXP)
- Date/Time: Jan 24, 7:00 AM (ET)
- Est. Revenue: $17.14B
- Est. EPS: $2.98
- Key Focus: Consumer spending patterns, travel activity, and premium cardholder growth are central to AXP’s outlook.
Verizon (VZ)
- Date/Time: Jan 24, 7:02 AM (ET)
- Est. Revenue: $33.73B
- Est. EPS: $1.17
- Key Focus: Wireless subscriber numbers and 5G network advancements remain top issues for telecom investors.
NextEra Energy (NEE)
- Date/Time: Jan 24, 7:30 AM (ET)
- Est. Revenue: $7.98B
- Est. EPS: $0.53
- Key Focus: Renewable energy capacity expansions and regulatory updates will influence NEE’s future growth.
HCA Healthcare (HCA)
- Date/Time: Jan 24, 7:30 AM (ET)
- Est. Revenue: $18.23B
- Est. EPS: $6.16
- Key Focus: Hospital admission trends and elective procedure volumes are vital indicators of HCA’s performance.
Now that we’re back in earnings season, this week’s announcements span multiple sectors—ranging from industrials and finance to tech and consumer staples—offering investors a broad snapshot of how companies are navigating economic headwinds, supply chain challenges, and shifting consumer demand. While top-line results and EPS figures are crucial, forward-looking guidance and strategic commentary often hold the key to understanding each company’s trajectory.